SCHEMBL24815692

SCHEMBL24815692

O=C(CCS(=O)(=O)c1nccs1)N1Cc2ccccc2C1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.44
▸ RAB9A P51151 6/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ LMNA P02545 2/20 0.42
▸ GAA P10253 2/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ CYP2D6 P10635 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ PKM P14618 2/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ POLB P06746 1/20 0.40
▸ HPGD P15428 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ NAMPT P43490 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ DPP4 P27487 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29987376 1.00 ALDH1A1 (0.44) ALDH1A1RAB9ANPC1LMNAGAA
SCHEMBL24815669 0.87 SMN1; SMN2 (0.42) ALDH1A1RAB9ANPC1LMNACYP1A2
SCHEMBL29986905 0.87 SMN1; SMN2 (0.42) ALDH1A1RAB9ANPC1LMNACYP1A2
SCHEMBL29987602 0.76 RAB9A (0.65) ALDH1A1RAB9ANPC1GAASMN1; SMN2
SCHEMBL24814720 0.76 RAB9A (0.65) ALDH1A1RAB9ANPC1GAASMN1; SMN2
SCHEMBL29987551 0.75 MAOB (0.39) LMNASMN1; SMN2NAMPT
SCHEMBL24814392 0.75 DPP8 (0.41) ALDH1A1RAB9ANPC1LMNACYP1A2
SCHEMBL29986896 0.75 DPP8 (0.41) ALDH1A1RAB9ANPC1LMNACYP1A2
SCHEMBL24817122 0.74 NAMPT (0.44) NAMPTDPP4
SCHEMBL24817127 0.74 MAOB (0.40) ALDH1A1LMNASMN1; SMN2HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH ALDH1A1 3533/4885RAB9A 2375/4885NPC1 2299/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH ALDH1A1 3533/4885RAB9A 2375/4885NPC1 2299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback